Hercules Capital, Inc. (HTGC)
HTGC · NYSE
Palo Alto, CA | NYSE:HTGC
Overview
Hercules Capital is a leading BDC focused exclusively on venture debt financing for technology and life sciences companies. HTGC provides senior secured loans to venture capital-backed companies that are typically pre-profit or pre-revenue but have strong institutional backing. With a specialization in venture debt, Hercules offers a differentiated BDC investment with higher yield potential and unique exposure to innovation-driven growth companies.
Key Metrics
| Metric | Value |
|---|---|
| 1-Year Total Return | 17.2% |
| 3-Year Total Return | 42.5% |
| 5-Year Total Return | 61% |
| Expense Ratio | 9.5% |
| Leverage Ratio | 1.35x |
| Portfolio Companies | 155 |
| Total Assets | $3.7B |
Investment Strategy
Hercules Capital, Inc. focuses on venture debt, senior secured loans in the technology, life sciences, healthcare, climate tech sectors. The company targets middle-market companies and maintains a portfolio of 155 investments totaling $3.7B in assets.
Management
CEO: Scott Bluestein | Employees: 65
Suitability
HTGC is suitable for income-focused investors seeking quarterly dividend income with a 9.8% yield. The BDC's focus on venture debt provides portfolio characteristics. Investors should consider their risk tolerance and investment objectives before investing.